Search

Your search keyword '"Giobbie‐Hurder, Anita"' showing total 1,034 results

Search Constraints

Start Over You searched for: Author "Giobbie‐Hurder, Anita" Remove constraint Author: "Giobbie‐Hurder, Anita"
1,034 results on '"Giobbie‐Hurder, Anita"'

Search Results

52. Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy

61. 218 Prospective spatial immune cell profiling identifies features of the tumor-immune microenvironment associated with genomic alterations and patient survival in a 2,023 patient pan-cancer cohort

65. EDIL3 as an angiogenic target of immune exclusion following checkpoint blockade

68. Phase II trial of vaccination with autologous, irradiated melanoma cells engineered by adenoviral mediated gene transfer to secrete granulocytemacrophage colony stimulating factor in patients with stage III and IV melanoma.

69. Exploring anxiety as an influencing factor of the impact of exercise and mind-body prehabilitation on cognitive functioning among women undergoing breast cancer surgery.

70. Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance.

73. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

74. Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy

75. Data from Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients

76. Supplementary Data 1 from Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients

88. Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients

91. Conducting a three-country clinical trial during the COVID-19 pandemic: experience and future considerations

92. Dose‐escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF ‐mutant solid tumors

93. Abstract 3249: Circulating cytokine associations with clinical outcomes in melanoma patients treated with checkpoint inhibitors

94. Abstract 5706: ImmunoPROFILE: A prospective implementation of clinically validated, quantitative immune cell profiling test identifies tumor-infiltrating CD8+ and PD-1+ cell densities as prognostic biomarkers across a 2,023 patient pan-cancer cohort treated with different therapies

95. Data from The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor–Related Thyroid Disorders

96. Supplementary Data from The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor–Related Thyroid Disorders

97. Abstract 965: Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma

99. Data from An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer

100. Data from A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer

Catalog

Books, media, physical & digital resources